|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00000218 |
|
Date of registration:
|
20/09/1999 |
|
Primary sponsor: |
|
|
Public title:
|
Pharmacotherapy and Intensive Treatment - 2
|
|
Scientific title:
|
Pharmacotherapy and Intensive Treatment |
|
Date of first enrolment:
|
January 1992 |
|
Target sample size:
|
353 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00000218 |
|
Study type:
|
Interventional |
|
Study design:
|
Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
William Haning, M.D. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Kansas |
| | |
|
Key inclusion & exclusion criteria
|
Please contact site for information.
Age minimum:
18 Years
Age maximum:
60 Years
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Cocaine-Related Disorders
|
|
Substance-Related Disorders
|
|
Intervention(s)
|
|
Drug: Carbamazepine
|
|
Primary Outcome(s)
|
|
Depression
|
|
Depression, anxiety
|
|
Severity addiction
|
|
Secondary ID(s)
|
|
NIDA-06954-2
|
|
R18-06954-2
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|